O-GlcNAc Antibodies

Santa Cruz Biotechnology provides a broad selection of O-GlcNAc monoclonal antibodies for advanced research in the field of glycosylation. O-GlcNAc monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). O-GlcNAcylation is a critical post-translational modification that plays a significant role in regulating protein function, cellular signaling, and stress responses. The modification process influences various biological mechanisms, including cell cycle regulation, transcription, and metabolism, making O-GlcNAc a key player in both normal physiology and disease states such as cancer and neurodegeneration. Understanding the dynamics of O-GlcNAcylation provides crucial insights into cellular functions and disease mechanisms. Researchers can effectively track and analyze O-GlcNAc modifications across different cellular environments and experimental conditions. Advanced visualization techniques allow for precise monitoring of O-GlcNAc activity in living cells. Detailed mapping of O-GlcNAc modifications helps reveal new therapeutic targets for various diseases. Santa Cruz Biotechnology monoclonal antibodies for O-GlcNAc research support scientists worldwide in advancing our understanding of cellular processes and disease mechanisms.